FDA Determines Regulatory Review Period for BARRICAID ANULAR CLOSURE DEVICE Patent Extension

Summary

The US Food and Drug Administration (FDA) has published a notice determining the regulatory review period for the extension of a patent for the BARRICAID ANULAR CLOSURE DEVICE, a medical device, following submissions to the US Patent and Trademark Office (USPTO).